Sporadic upper urinary tract urothelial cell carcinomas: Identification of interaction between toxic carcinogens and individuals genetic susceptibility;Tumeurs des voies excrétrices urinaires supérieures sporadiques : identification de l'interaction entre l'exposition aux carcinogènes environnementaux et la susceptibilité génétique des individus

Progres en Urologie

Volumn 20, Issue 1, 2010, Pages 1-10

  Colin, P ^a,b   Koenig, P ^a   Ballereau, C ^a   Phe V ^a,c   Berthon, N ^a   Villers, A ^a,b   Biserte, J ^a   Roupret M ^c,d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Aristolochic acid; Genetic polymorphism; MeSH; Renal pelvis; Risk factor; Ureter; Urothelial carcinoma

Indexed keywords

EID: 73849095428     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2009.10.010     Document Type: Short Survey

References (40)

1. Mazeman E. Tumeurs des voies excrètrices supérieures, Calices, Bassinet. Uretère. J Urol Nephrol (Paris) 78 Suppl. 9 (1972) 1-219
2. Munoz J.J., and Ellison L.M. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164 5 (2000) 1523-1525
3. van der Poel H.G., Antonini N., van Tinteren H., and Horenblas S. Upper urinary tract cancer: location is correlated with prognosis. Eur Urol 48 3 (2005) 438-444
4. Fernandez M.I., Shariat S.F., Margulis V., Bolenz C., Montorsi F., Suardi N., et al. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Urology 73 1 (2009) 142-146
5. Catto J.W., Yates D.R., Rehman I., Azzouzi A.R., Patterson J., Sibony M., et al. Behavior of urothelial carcinoma with respect to anatomical location. J Urol 177 5 (2007) 1715-1720
6. Roupret M. Interet clinique à la corrélation phénotype/génotype pour la prise en charge des cancers des voies excrètrices supérieures. Prog Urol 16 4 Suppl. FMC (2006) 15-20
7. Bouyer J, Épidémiologie. Principes et méthodes quantitatives 1997: Inserm.
8. Hung R.J., Boffetta P., Brennan P., Malaveille C., Hautefeuille A., Donato F., et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 110 4 (2004) 598-604
9. Bringuier P.P., McCredie M., Sauter G., Bilous M., Stewart J., Mihatsch M.J., et al. Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolising enzymes. Int J Cancer 79 5 (1998) 531-536
10. Pommer W., Bronder E., Klimpel A., Helmert U., Greiser E., and Molzahn M. Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant 14 12 (1999) 2892-2897
11. McLaughlin J.K., Silverman D.T., Hsing A.W., Ross R.K., Schoenberg J.B., Yu M.C., et al. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 52 2 (1992) 254-257
12. Saint F., Petit J., and Doutrelot-Philipon C. Tumeurs de vessie professionnelles : modalités pratiques pour leur reconnaissance en maladie profesionnelle. Prog Urol 13 5 Suppl. 2 (2003) 1215-1224
13. Shinka T., Miyai M., Sawada Y., Inagaki T., and Okawa T. Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic amines. Int J Urol 2 4 (1995) 243-248
14. McCredie M., and Stewart J.H. Risk factors for kidney cancer in New South Wales. IV. Occupation. Br J Ind Med 50 4 (1993) 349-354
15. Wilson R.T., Donahue M., Gridley G., Adami J., El Ghormli L., and Dosemeci M. Shared occupational risks for transitional cell cancer of the bladder and renal pelvis among men and women in Sweden. Am J Ind Med 51 2 (2008) 83-99
16. Pesch B., Haerting J., Ranft U., Klimpel A., Oelschlägel B., Schill W., et al. Occupational risk factors for urothelial carcinoma: agent-specific results from a case-control study in Germany. Int J Epidemiol 29 2 (2000) 238-247
17. Espinoza F., Silverman D., Kogevinas M., Creus A., Fernández F., García-Closas M., et al. Micronuclei assessment in the urothelial cells of women using hair dyes and its modulation by genetic polymorphisms. Cancer Lett 263 2 (2008) 259-266
18. Holmang S., and Johansson S.L. Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome. Cancer 101 4 (2004) 741-747
19. Stewart J.H., Hobbs J.B., and McCredie M.R. Morphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvis. Cancer 86 8 (1999) 1576-1582
20. Markovic N., Ivan Ignjatovic, Rade Cukuranovic, Branislav Petrovic, Biljana Kocic, Vladisav, and Stefanovic. Decreasing incidence of urothelial cancer in a Balkan endemic nephropathy region in Serbia. A surgery based study from 1969 to 1998. Pathol Biol Paris 53 1 (2005) 26-29
21. Grollman A.P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci U S A 104 29 (2007) 12129-12134
22. Debelle F.D., Vanherweghem J.L., and Nortier J.L. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74 2 (2008) 158-169
23. Dragicevic D., Djokic M., Pekmezovic T., Micic S., Hadzi-Djokic J., Vuksanovic A., et al. Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia. BJU Int 99 6 (2007) 1357-1362
24. Nortier J.L., Martinez M.C., Schmeiser H.H., Arlt V.M., Bieler C.A., Petein Met al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342 23 (2000) 1686-1692
25. Lord G.M., Cook T., Arlt V.M., Schmeiser H.H., Williams G., and Pusey C.D. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 358 9292 (2001) 1515-1516
26. Stiborova M., Frei E., and Schmeiser H.H. Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid. Kidney Int 73 11 (2008) 1209-1211
27. Tan L.B., Chen K.T., and Guo H.R. Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan. BJU Int 102 1 (2008) 48-54
28. Yang M.H., Chen K.K., Yen C.C., Wang W.S., Chang Y.H., Huang W.J., et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology 59 5 (2002) 681-687
29. Chiou H.Y., Chiou S.T., Hsu Y.H., Chou Y.L., Tseng C.H., Wei M.L., et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153 5 (2001) 411-418
30. Lamm S.H., Engel A., Penn C.A., Chen R., and Feinleib M. Arsenic cancer risk confounder in southwest Taiwan data set. Environ Health Perspect 114 7 (2006) 1077-1082
31. Ravault BFC, Ledrans M. Exposition chronique à l'arsenic hydrique et risques pour la santé. 2003.
32. Chow W.H., Lindblad P., Gridley G., Nyrén O., McLaughlin J.K., Linet M.S., et al. Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 89 19 (1997) 1453-1457
33. McCredie M., and Stewart J.H. Risk factors for kidney cancer in New South Wales. Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control 3 4 (1992) 323-331
34. Kaldor J.M., Day N.E., Kittelmann B., Pettersson F., Langmark F., Pedersen D., et al. Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study. Int J Cancer 63 1 (1995) 1-6
35. Irani J. Tumeurs urothéliales induites par le chimiothéérapie et la radiothérapie. Prog Urol 13 5 Suppl. 2 (2003) p. 1232
36. McDougal W.S., Cramer S.F., and Miller R. Invasive carcinoma of the renal pelvis following cyclophosphamide therapy for nonmalignant disease. Cancer 48 3 (1981) 691-695
37. Liaw K.L., Linet M.S., McLaughlin J.K., Yu M.C., Schoenberg J.B., Lynch C.F., et al. Possible relation between hypertension and cancers of the renal pelvis and ureter. Int J Cancer 70 3 (1997) 265-268
38. De Stefani E., Boffetta P., Deneo-Pellegrini H., Correa P., Ronco A.L., Brennan P., et al. Non-alcoholic beverages and risk of bladder cancer in Uruguay. BMC Cancer 7 (2007) p57
39. Horikawa Y., Gu J., and Wu X. Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions. Curr Opin Urol 18 5 (2008) 493-498
40. Roupret M., Cancel-Tassin G., Comperat E., Fromont G., Sibony M., Molinié V., et al. Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma. Cancer Epidemiol Biomarkers Prev 16 11 (2007) 2500-2503